Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.
InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2017. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website, www.indexpharma.com
Annual General Meeting in InDex Pharmaceuticals Holding AB will be held on May 24, 2018 at 5:00 p.m. (CET) at the company´s premises, Tomtebodavägen 23a in Stockholm, Sweden. Registration for the meeting will begin at 4:30 p.m.
Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820, are hereby summoned to the Annual General Meeting on May 24, 2018 at 5:00 p.m. (CET) at the company´s premises, Tomtebodavägen 23a in Stockholm, Sweden. Registration for the meeting begins at 4:30 p.m.
NORTH CHICAGO, Ill., April 18, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Deutsche Bank's 43rd Annual Health Care Conference on Wednesday, May 9, 2018. Bill Chase, executive vice president and chief financial officer, will present at 7 a.m. Central time.
April 12th, 2018 - InDex Pharmaceuticals Holding AB (publ) (”InDex”) today announced the agenda for its Capital Markets Day that will take place in Stockholm on Wednesday April 25, 2018, for investors, analysts and media.
Professor Harald Stenmark is granted the European Research Council’s (ERC) Advanced Grant for his cancer research. This is the second time he receives the grant; a privilege that has only befallen two other people, professor Edvard Moser (NTNU) and professor Kenneth Hugdahl (UiB).